Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)

  • Steven Simoens*
  • , David Dodwell
  • , Michael Hartevelt
  • , Peter Lindgren
  • , Michele Pistollato
  • , Lisa G. Pont
  • , Caridad Pontes
  • , Alexander Roediger
  • , Antun Sablek
  • , Eric Van Ganse
  • , Qinyi Wang
  • , Chris Wenger
  • , Tim Wilsdon
  • , Entela Xoxi
  • , Brian Godman
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Author Entela Xoxi was erroneously assigned to affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom. This affiliation has now been removed for author Entela Xoxi. Author Lisa G. Pont was erroneously spelled as Lisa Pont. The original article has been updated.

Original languageEnglish
Article number1693232
JournalFrontiers in Pharmacology
Volume16
DOIs
Publication statusPublished - 2025

Keywords

  • Australia
  • Europe
  • individual patient-level healthcare data
  • oncology combination therapies
  • pharmaceutical policy
  • pricing and reimbursement
  • utilization tracking

Fingerprint

Dive into the research topics of 'Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)'. Together they form a unique fingerprint.

Cite this